Detection of DNA-strand breaks in cells treated with F 11782, a catalytic inhibitor of topoisomerases I and II

Anticancer Research

Volumn 20, Issue 6 B, 2000, Pages 4557-4562

  Barret, J M ^a   Montaudon, D ^a   Etievant C ^a   Perrin, D ^a   Kruczynski, A ^a   Robert, J ^a   Hill, B T ^a  

^a INSTITUT DE RECHERCHE PIERRE FABRE   (France)

Author keywords

Catalytic topoisomerase inhibitor; DNA damage; DNA strand breaks; F 11782

Indexed keywords

CAMPTOTHECIN; DNA TOPOISOMERASE INHIBITOR; ETOPOSIDE; F 11782; GYRASE INHIBITOR; NAVELBINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; DNA DAMAGE; DNA STRAND BREAKAGE; DOSE TIME EFFECT RELATION; DRUG CYTOTOXICITY; DRUG MECHANISM; ENZYME INHIBITOR INTERACTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; DNA DAMAGE; DNA REPAIR; DNA TOPOISOMERASES, TYPE I; DNA, NEOPLASM; ENZYME INHIBITORS; ETOPOSIDE; LEUKEMIA P388; NAPHTHALENES; NUCLEIC ACID SYNTHESIS INHIBITORS; PYRANS; RADIATION-SENSITIZING AGENTS; RATS; TUMOR CELLS, CULTURED; VINBLASTINE;

EID: 0034480302     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Antitumor inhibitors of DNA topoisomerases
2. Intercalation into DNA is not required for inhibition of topoisomerase I by indolocarbazole antitumor agents
3. Eukaryotic DNA topoisomerase I
4. DNA topoisomerases: Essential enzymes and lethal targets
5. Catalytic inhibitors of DNA topoisomerase II
6. Synthesis and antitumor activity of a novel epipodophylloid: F 11782, a dual inhibitor of topoisomerases I and II
7. F 11782, a novel epipodophylloid non-intercalating dual catalytic inhibitor of topoisomerase I and II with original mechanism of action
8. Preclinical antitumour activity of F 11782, a novel dual non-intercalating catalytic inhibitor of topoisomerases I and II
9. F11782 a dual inhibitor of topoisomerases I and II with an original mechanism of action in vitro, and markedly superior in vivo antitumour activity, relative to three other dual inhibitors, intoplicin, aclarubicin and TAS-103
10. A fluorescence enhancement assay for cellular DNA damage
11. Principles and practice of DNA filter elution
12. Vinflunine (20′, 20′ -difluoro-3′, 4′ -dihydrovinorelbine), a novel vinca alkaloid, which participates in P- glycoprotein (Pgp)-mediated multidrug resistance in vivo and in vitro
13. Differential stabilization of topoisomerase-II-DNA cleavable complexes by doxorubicin and etoposide in doxorubicin-resistant rat glioblastoma cells
14. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications
15. Single- and double-strand DNA breakage and repair in human lung adenocarcinoma cells exposed to etoposide and teniposide
16. Topoisomerase II mediated DNA breaks and cytotoxicity in relation to cell proliferation and the cell cycle in NIH 3T3 fibroblasts and L1210 leukemia cells
17. Differences in inhibition of chromosome separation and G2 arrest by DNA topoisomerase II inhibitors merbarone and VM-26
18. Inhibition of intracellular topoisomerase II by antitumor bis(2,6-dioxopiperazine) derivatives: Mode of cell growth inhibition distinct from that of cleavable complex- forming type inhibitors
19. A topoisomerase II-dependent G2 cycle checkpoint in mammalian cells
20. Effects of the DNA topoisomerase II inhibitor merbarone in male mouse meiotic division in vivo: Cell cycle arrest and induction of aneuploidy
21. Antagonistic effect of aclarubicin on the cytotoxicity of etoposide and 4′-(9-acridinylamino)-methanesulfon-manisidide in human small cell lung cancer cell lines and on topoisomerase II-mediated DNA cleavage
22. Unique cross-resistance profile of a P388 leukemia subline selected in vivo for resistance to F 11782, a novel dual catalytic inhibitor of topoisomerases I and II, associated with down-regulation of topoisomerase IIa